Literature DB >> 10551310

Reversible retinal toxicity associated with retained intravitreal copper foreign body in the absence of intraocular inflammation.

M R Dayan1, D G Cottrell, K W Mitchell.   

Abstract

PURPOSE: To report on a patient who developed retinal toxicity from an intraocular copper foreign body in the absence of any signs of chalcosis or inflammation.
METHOD: Case report. RESULT: Removal of the copper foreign body resulted in electroretinographic improvement and the patient has retained good vision.
CONCLUSION: Retinal toxicity from intraocular copper can be subclinical and such foreign bodies should be removed. Removal of the foreign body can be associated with at least partial reversal of retinal toxicity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10551310     DOI: 10.1034/j.1600-0420.1999.770525.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  4 in total

1.  Evaluating the anticancer properties of liposomal copper in a nude xenograft mouse model of human prostate cancer: formulation, in vitro, in vivo, histology and tissue distribution studies.

Authors:  Yan Wang; San Zeng; Tien-Min Lin; Lisa Krugner-Higby; Doug Lyman; Dana Steffen; May P Xiong
Journal:  Pharm Res       Date:  2014-05-22       Impact factor: 4.200

2.  Copper foreign body in the lens without damage of iris and lens capsule.

Authors:  Mayumi Tokoro; Tsutomu Yasukawa; Morio Okada; Yuichiro Ogura; Sunao Uchida
Journal:  Int Ophthalmol       Date:  2007-05-15       Impact factor: 2.031

3.  Occult intraocular foreign body masquerading as panuveitis: inductively coupled mass spectrometry and electrophysiologic analysis.

Authors:  Steven Yeh; Martina Ralle; Isabella T Phan; Peter J Francis; James T Rosenbaum; Christina Joy Flaxel
Journal:  J Ophthalmic Inflamm Infect       Date:  2011-07-31

4.  Correlation Between Electroretinogram and Visual Prognosis in Metallic Intraocular Foreign Body Injury.

Authors:  Xiaoting Mai; Fangyi Ling; Yuting Gong; Jialin Chen; Hongjie Lin; Haoyu Chen
Journal:  Front Med (Lausanne)       Date:  2021-06-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.